Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
November 08, 2023 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (“Orgenesis”) (Nasdaq: ORGS), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs),...
Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding
November 02, 2023 08:00 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
Orgenesis Announces Withdrawal of Proposed Public Offering
October 30, 2023 21:30 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
Orgenesis Announces Proposed Underwritten Public Offering
October 30, 2023 16:07 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States
September 21, 2023 08:00 ET
|
Orgenesis Inc.
GERMANTOWN, Maryland, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support
September 06, 2023 07:00 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Orgenesis, a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), continues to grow the infrastructure...
Personal-Use Self-Monitoring Blood Glucose Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
August 16, 2023 13:24 ET
|
ReportLinker
New York, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Personal-Use Self-Monitoring Blood Glucose Devices Market Size & Share Analysis - Growth Trends...
Orgenesis Provides Business Update for Second Quarter of 2023
August 11, 2023 07:00 ET
|
Orgenesis Inc.
Reports Progress in Advancing the Rollout of the POCare Platform and POCare Therapeutic Pipeline Orgenesis to Host Conference Call Today at 8:00 AM ET GERMANTOWN, Md., Aug. 11,...
Orgenesis Schedules Second Quarter 2023 Business Update Conference Call
August 10, 2023 08:30 ET
|
Orgenesis Inc.
GERMANTOWN, Md., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
North America Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
July 17, 2023 11:58 ET
|
ReportLinker
New York, July 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends &...